Voyager Therapeutics participated in a conference in Boston, MA, on August 26, 2025, involving Baird and programs derived from the TRACER AAV platform.
2 reports, 2 independent
Updated Jun 30
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Voyager Therapeutics participated in a conference in Boston, MA, on August 26, 2025, involving Baird and programs derived from the TRACER AAV platform.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Voyager Therapeutics listed on Nasdaq and announced research program for Huntington's disease using Tracer.1 source
Voyager participated in a Baird conference in Boston, featuring TRACER platform programs.1 source
Keep exploring
The entities involved
-
Voyager Therapeutics (United States)
company in Cambridge, United States
Nothing else this week.
-
Baird
financial services provider
Nothing else this week.
Coverage
Newest first; wire copies grouped- yahoo.com
- GlobeNewswireVoyager to Present at Upcoming Investor Conferences LEXINGTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging gene